Tivic Health Systems Faces Delisting Concerns
Ticker: TIVC · Form: 8-K · Filed: Jul 3, 2024 · CIK: 1787740
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: TIVC
TL;DR
Tivic Health (TIVC) is on notice for potential delisting.
AI Summary
Tivic Health Systems, Inc. filed an 8-K on June 28, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in Fremont, California, and its principal executive offices are located at 47685 Lakeview Blvd.
Why It Matters
This filing indicates potential issues with Tivic Health Systems' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall viability.
Key Players & Entities
- Tivic Health Systems, Inc. (company) — Registrant
- June 28, 2024 (date) — Date of earliest event reported
- 47685 Lakeview Blvd. (address) — Principal Executive Offices
- Fremont, California (location) — Principal Executive Offices Location
FAQ
What specific listing rule or standard has Tivic Health Systems failed to satisfy?
The filing does not specify the exact rule or standard that Tivic Health Systems has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 28, 2024.
Where are Tivic Health Systems' principal executive offices located?
Tivic Health Systems' principal executive offices are located at 47685 Lakeview Blvd., Fremont, California, 94538.
What is the company's telephone number?
The company's telephone number, including area code, is 888 276-6888.
What is the Standard Industrial Classification (SIC) code for Tivic Health Systems?
The Standard Industrial Classification (SIC) code for Tivic Health Systems is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 777 words · 3 min read · ~3 pages · Grade level 14.4 · Accepted 2024-07-03 17:00:20
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share TIVC The Nasdaq Stock Mar
- $1.00 — or the Company's common stock was below $1.00 per share for 33 consecutive business d
Filing Documents
- tivc-20240628.htm (8-K) — 38KB
- 0000950170-24-081608.txt ( ) — 149KB
- tivc-20240628.xsd (EX-101.SCH) — 24KB
- tivc-20240628_htm.xml (XML) — 5KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 28, 2024, Tivic Health Systems, Inc. (the "Company") received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, because the closing bid price for the Company's common stock was below $1.00 per share for 33 consecutive business days, the Company is not currently in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). The notification has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market, and, therefore, the Company's listing remains fully effective. In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from June 27, 2024, or until December 26, 2024, to regain compliance with the Minimum Bid Price Requirement. If at any time before December 26, 2024, the closing bid price of the Company's common stock closes at or above $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written notification that the Company has achieved compliance with the Minimum Bid Price Requirement, and the matter would be resolved. If the Company does not regain compliance during the compliance period ending on December 26, 2024, then Nasdaq may grant the Company a second 180 calendar day grace period to regain compliance, provided the Company (i) meets the continued listing requirement for market value of publicly-held shares and all other initial listing standards for the Nasdaq Capital Market, other than the minimum closing bid price requirement, and (ii) the Company notifies Nasdaq of its intent to cure the deficiency. The Company intends to continue actively monitoring the closing bid price for the Company's common stock be
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TIVIC HEALTH SYSTEMS, INC. Date: July 3, 2024 By: /s/ Jennifer Ernst Name: Jennifer Ernst Title: Chief Executive Officer